시장보고서
상품코드
1629204

전임상용 플루이딕스 시장 : 제품별, 용도별, 최종사용자별, 국가별, 지역별 - 산업 분석, 시장 규모 및 점유율, 예측(2024-2032년)

Fluidics for Preclinical Market, By Product, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

발행일: | 리서치사: AnalystView Market Insights | 페이지 정보: 영문 284 Pages | 배송안내 : 2-3일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

리포트 하이라이트

전임상용 플루이딕스 시장 규모는 2023년에 41억 2,043만 달러에 달하며, 2024-2032년에 CAGR 6.33%로 확대

전임상용 플루이딕스 시장 역학

마이크로플루이딕스 기술 발전, 신약 개발, 비용 효율성 향상으로 시장 수요 촉진 전망

전임상용 유체 시장은 생명공학의 발전과 효율적인 신약개발에 대한 수요 증가로 인해 빠르게 성장하고 있습니다. 최근 마이크로유체공학의 혁신은 전임상 연구에 혁명을 가져왔으며, 첨단 랩온칩 시스템 및 장기 칩 플랫폼의 개발을 가능하게 했습니다. 이러한 장비는 유체 흐름을 정밀하게 제어하고 생리적 조건을 모방할 수 있으므로 복잡한 생물학적 과정을 연구하는 데 필수적인 툴이 되었습니다. 인간과 유사한 환경을 시뮬레이션할 수 있는 능력은 기존의 2차원 세포배양이나 동물 실험보다 더 정확한 모델을 연구자들에게 제공합니다. 제약 및 생명공학 산업은 의약품 개발 시간과 비용을 줄여야 한다는 압박에 직면해 있습니다. 플루이드믹스 기반 시스템은 높은 처리량 스크리닝 기능을 제공하여 통제된 조건에서 수천 개의 약물 후보물질을 신속하게 테스트할 수 있도록 합니다. 이를 통해 초기 단계의 연구를 가속화하고 임상 결과 예측을 개선할 수 있습니다.

유체 기반 기술은 기존 방법에 비해 적은 양의 시료, 적은 시약, 적은 노동력을 필요로 하므로 비용 효율성이 높습니다. 이는 연구 예산이 한정된 중소기업(SME)이나 학술기관에 특히 유리합니다. 또한 이러한 시스템의 확장성은 신약 개발에서 높은 처리량 용도를 지원합니다. 플루이딕스와 AI, 3D 프린팅, 바이오인포매틱스의 통합은 그 적용 범위를 넓혀가고 있습니다. 학계, 산업계, 정부 간의 협력은 플루이딕스를 기반으로 한 새로운 전임상 툴의 개발을 가속화하고 시장 성장을 가속하고 있습니다.

전임상용 플루이딕 시장 : 주요 고려사항

당사의 리서치 애널리스트들의 분석에 따르면 세계 시장은 예측 기간(2024-2032년) 동안 연평균 약 6.33%%의 연평균 복합 성장률(CAGR)로 매년 성장할 것으로 예상됩니다.

제품별로 보면 AI 및 빅데이터 분석 분야에서 소프트웨어 솔루션의 채택이 증가함에 따라 소프트웨어 및 액세서리 부문이 2023년에 가장 높은 시장 점유율을 보였습니다.

용도별로는 mRNA 백신, 면역측정 기술 등 수요 증가로 인해 임상 부문이 2023년 주요 용도가 될 것으로 예상됩니다.

최종사용자별로 보면 감염성 질환의 높은 유행으로 인해 병원 부문이 2023년 주요 최종사용자 부문이 될 것으로 보입니다.

지역별로는 의료 인프라가 잘 구축된 북미가 2023년 주요 수입원으로 꼽혔습니다.

전임상용 플루이딕스 시장 : 세분화 분석

전임상 플루이드 세계 시장은 제품, 애플리케이션, 최종사용자, 지역별로 분류됩니다.

제품은 정밀 주사기 펌프와 소프트웨어 및 액세서리 두 가지로 나뉩니다. 소프트웨어 및 서비스 분야가 시장을 독점하고 있습니다. 마이크로플루이딕스 키트의 기술 발전이 이 부문 수요에 기여하고 있습니다.

시장은 용도별로 임상, 생명과학 연구, 기타 세 가지로 분류됩니다. 예측 기간 중 임상 분야가 우위를 차지할 것으로 예상됩니다. 생명과학 연구 분야는 신약 전임상 연구에 대한 투자 증가로 인해 가장 빠른 속도로 성장할 것으로 예상됩니다.

시장은 최종사용자별로 병원, 클리닉, 기타 세 가지로 분류됩니다. 병원 부문이 시장을 독점하고 있으며, 예측 기간 중 높은 우위를 유지할 것으로 예상됩니다. 심혈관, 당뇨병과 같은 만성질환의 유병률 증가와 현장 검사에 대한 수요가 증가하고 있습니다.

전임상용 플루이딕 시장 : 지역별 분석

전임상용 플루이드 시장은 북미, 라틴아메리카, 유럽, 아시아태평양, 중동 및 아프리카에 분포되어 있습니다. 북미가 전임상용 플루이딕스 시장을 독점하고 있는 것은 주로 연구 기관 및 학술 프로젝트에 대한 정부 및 민간 차원의 강력한 자금 지원 덕분입니다. 미국은 연간 임상시험 건수와 신약 승인 건수에서 선두를 달리고 있습니다. 유럽에서는 EU의 REACH 규제 등 동물실험을 제한하는 엄격한 법률이 있습니다. 독일, 영국, 프랑스 등의 국가에서는 학술적, 연구적 노력이 활발하게 진행되고 있습니다. 아시아태평양은 특히 중국과 인도에서 생명과학 연구에 대한 정부 투자가 증가하면서 가장 빠르게 성장하고 있는 지역입니다.

전임상용 플루이딕스 시장 : 경쟁 구도

전임상용 플루이딕스 시장은 경쟁이 치열하며, 많은 기업이 증가하는 전임상 연구 수요에 대응하기 위해 기술 혁신에 집중하고 있습니다. 주요 기업은 적극적으로 제품 포트폴리오를 강화하고 시장에서의 입지를 확대하고 있습니다. 전임상 연구에서 마이크로플루이딕스 기술 및 장기 칩 기술의 발전은 매우 중요합니다. 이러한 혁신은 유체 흐름을 정확하게 제어하고 생리적 조건을 모방하여 전임상 모델의 정확성을 향상시키며, Opentrons와 Emulate와 같은 주요 기업이 기술 발전을 주도하고 있습니다. 혁신적인 제품의 도입과 신흥 시장 진출이 향후 수년간 상당한 성장의 원동력이 될 것으로 예상됩니다.

목차

제1장 전임상용 플루이딕스 시장 개요

  • 조사 범위
  • 시장 추정 기간

제2장 개요

  • 시장 내역
  • 경쟁 인사이트

제3장 전임상용 플루이딕스의 주요 시장 동향

  • 시장 성장 촉진요인
  • 시장 성장 억제요인
  • 시장 기회
  • 시장의 향후 동향

제4장 전임상용 플루이딕스 시장 : 산업 분석

  • PEST 분석
  • Porter's Five Forces 분석
  • 시장 성장 전망 : 지도제작
  • 규제 체제 분석

제5장 전임상용 플루이딕스 시장 : COVID-19의 영향 분석

  • COVID-19 이전의 영향 분석
  • COVID-19 이후의 영향 분석

제6장 전임상용 플루이딕스 시장 구도

  • 전임상용 플루이딕스 시장 점유율 분석(2024년)
  • 주요 제조업체별 내역 데이터
    • 기존 기업의 분석
    • 신규 기업의 분석

제7장 전임상용 플루이딕스 시장 : 제품별

  • 개요
    • 부문별 점유율 분석 : 제품별
    • 정밀 시린지 펌프
    • 소프트웨어·부속품

제8장 전임상용 플루이딕스 시장 : 용도별

  • 개요
    • 부문별 점유율 분석 : 용도별
    • 임상
    • 생명과학 연구
    • 기타

제9장 전임상용 플루이딕스 시장 : 최종사용자별

  • 개요
    • 부문별 점유율 분석 : 최종사용자별
    • 병원
    • 클리닉
    • 기타

제10장 전임상용 플루이딕스 시장 : 지역별

  • 서론
  • 북미
    • 개요
    • 북미의 주요 제조업체
    • 미국
    • 캐나다
  • 유럽
    • 개요
    • 유럽의 주요 제조업체
    • 독일
    • 이탈리아
    • 영국
    • 프랑스
    • 러시아
    • 네덜란드
    • 스웨덴
    • 폴란드
    • 기타
  • 아시아태평양(APAC)
    • 개요
    • 아시아태평양의 주요 제조업체
    • 인도
    • 중국
    • 일본
    • 한국
    • 호주
    • 태국
    • 인도네시아
    • 필리핀
    • 기타
  • 라틴아메리카
    • 개요
    • 라틴아메리카의 주요 제조업체
    • 브라질
    • 멕시코
    • 아르헨티나
    • 콜롬비아
    • 기타
  • 중동 및 아프리카
    • 개요
    • 중동 및 아프리카의 주요 제조업체
    • 사우디아라비아
    • 아랍에미리트
    • 이스라엘
    • 터키
    • 알제리
    • 이집트
    • 기타

제11장 주요 벤더 분석 : 전임상용 플루이딕스 업계

  • 경쟁 대시보드
  • 기업 개요
    • Danaher Corporation
    • Thermo Fisher Scientific
    • Emulate, Inc.
    • Opentrons Labworks
    • Dolomite Microfluidics
    • PerkinElmer, Inc.
    • Illumina, Inc.
    • Agilent Technologies
    • Fluidigm Corporation
    • Bio-Rad Laboratories
    • Tecan Group Ltd.
    • CN Bio Innovations
    • Mimetas BV
    • Axion BioSystems
    • Roche Diagnostics
    • Others

제12장 AnalystView의 전방위적 분석

KSA 25.02.13

REPORT HIGHLIGHT

Fluidics for Preclinical Market size was valued at USD 4,120.43 Million in 2023, expanding at a CAGR of 6.33% from 2024 to 2032.

Fluidics for preclinical applications involves the use of fluidic systems, such as microfluidic devices or engineered fluid flows, to study biological, chemical, or pharmaceutical processes in the early stages of medical research. These systems are highly relevant in preclinical research for testing new drugs, studying disease mechanisms, or exploring the behavior of cells and biomolecules in controlled environments.

Fluidics for Preclinical Market- Market Dynamics

Growing advancement in microfluidic technology, drug discoveries and cost-effectiveness benefits are expected to propel market demand

The fluidics for preclinical market is growing rapidly, driven by advancements in biotechnology, increasing demand for efficient drug discovery methods. Recent innovations in microfluidics have revolutionized preclinical research, enabling the development of sophisticated lab-on-a-chip systems and organ-on-chip platforms. These devices allow precise control over fluid flows and mimic physiological conditions, making them indispensable tools for studying complex biological processes. Their ability to simulate human-like environments provides researchers with more accurate models than traditional 2D cell cultures or animal testing. The pharmaceutical and biotechnology industries face mounting pressure to reduce the time and cost of drug development. Fluidics-based systems provide high-throughput screening capabilities, enabling rapid testing of thousands of drug candidates under controlled conditions. This accelerates early-stage research while improving the prediction of clinical outcomes.

Fluidics-based technologies are cost-effective compared to traditional methods, requiring smaller sample volumes, fewer reagents, and less labor. This is particularly advantageous for small and medium-sized enterprises (SMEs) and academic institutions that may have limited research budgets. Furthermore, the scalability of these systems supports high-throughput applications in drug discovery. The integration of fluidics with AI, 3D printing, and bioinformatics is expanding its applications. Collaborative efforts between academia, industry, and government are accelerating the development of novel fluidics-based preclinical tools, boosting market growth.

Fluidics for Preclinical Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 6.33% over the forecast period (2024-2032)

Based on Product segmentation, software & accessories segment was predicted to show maximum market share in the year 2023, owing to increasing adoption of software solutions in AI and big data analytics.

Based on Application segmentation, clinical segment was the leading application in 2023, due to rising demand for mRNA vaccines, immunoassay techniques, etc.

Based on End User segmentation, hospitals segment was the leading End User segment in 2023, due to high prevalence of infectious diseases.

On the basis of region, North America was the leading revenue generator in 2023, owing to presence of established healthcare infrastructure.

Fluidics for Preclinical Market- Segmentation Analysis:

The Global Fluidics for Preclinical Market is segmented on the basis of Product, Application, End User, and Region.

The market is divided into two categories based on Product: precision syringe pumps and software & accessories. The software & services segment dominates the market. The growing tech advancements in microfluidic kits are contributing to segment demand.

The market is divided into three categories based on the Application: clinical, life science research, and others. The clinical segment is expected to dominate over the forecast period. Life science research segment is estimated to grow at fastest rate owing to increasing investment in preclinical research for novel drugs.

The market is divided into three categories based on End User: hospitals, clinics, and others. The hospitals segment dominates the market and is expected to maintain its high dominance during the forecast period. The increasing prevalence of chronic disorders such as cardiovascular, diabetes and the demand for point of care testing.

Fluidics for Preclinical Market- Geographical Insights

Worldwide, the Fluidics for Preclinical market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Fluidics for Preclinical market, primarily due to the strong government and private funding for research institutions and academic projects. The U.S. leads in the number of clinical trials and new drug approvals annually. In Europe, stringent laws restricting animal testing, such as the European Union's REACH regulations. Strong academic and research initiatives in countries like Germany, the UK, and France. Asia Pacific is the fastest growing region with the increasing government investments in life sciences research, particularly in China and India.

Fluidics for Preclinical Market- Competitive Landscape:

The Fluidics for Preclinical Market is highly competitive, with numerous players focusing on innovations to cater to the increasing demand in preclinical research. Key players are actively enhancing their product portfolios and expanding their market presence. Advancements in microfluidics and organ-on-chip technologies are pivotal in preclinical research. These innovations offer precise control over fluid flows and mimic physiological conditions, enhancing the accuracy of preclinical models. Companies like Opentrons and Emulate leading technological advancements. The introduction of innovative products and the expansion into emerging markets are expected to drive substantial growth in the coming years.

Recent Developments:

In 2024, Opentrons introduced the Flex Prep, a no-code robot offering simplicity akin to a pipette with the versatility of a liquid handler.

In 2023, Opentrons launched the Flex lab robot, designed to democratize lab automation with an open-source API, facilitating integration with AI tools.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL FLUIDICS FOR PRECLINICAL MARKET KEY PLAYERS

  • Danaher Corporation
  • Thermo Fisher Scientific
  • Emulate, Inc.
  • Opentrons Labworks
  • Dolomite Microfluidics
  • PerkinElmer, Inc.
  • Illumina, Inc.
  • Agilent Technologies
  • Fluidigm Corporation
  • Bio-Rad Laboratories
  • Tecan Group Ltd.
  • CN Bio Innovations
  • Mimetas BV
  • Axion BioSystems
  • Roche Diagnostics
  • Others

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY PRODUCT- MARKET ANALYSIS, 2019-2032

  • Precision syringe pumps
  • Software & accessories

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Clinical
  • Life Science Research
  • Others

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospital
  • Clinics
  • Others

GLOBAL FLUIDICS FOR PRECLINICAL MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Fluidics for Preclinical Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Fluidics for Preclinical Market Snippet by Product
    • 2.1.2. Fluidics for Preclinical Market Snippet by Application
    • 2.1.3. Fluidics for Preclinical Market Snippet by End User
    • 2.1.4. Fluidics for Preclinical Market Snippet by Country
    • 2.1.5. Fluidics for Preclinical Market Snippet by Region
  • 2.2. Competitive Insights

3. Fluidics for Preclinical Key Market Trends

  • 3.1. Fluidics for Preclinical Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Fluidics for Preclinical Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Fluidics for Preclinical Market Opportunities
  • 3.4. Fluidics for Preclinical Market Future Trends

4. Fluidics for Preclinical Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Fluidics for Preclinical Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Fluidics for Preclinical Market Landscape

  • 6.1. Fluidics for Preclinical Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Fluidics for Preclinical Market - By Product

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product, 2024 & 2032 (%)
    • 7.1.2. Precision syringe pumps
    • 7.1.3. Software & accessories

8. Fluidics for Preclinical Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Clinical
    • 8.1.3. Life Science Research
    • 8.1.4. Others

9. Fluidics for Preclinical Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospital
    • 9.1.3. Clinics
    • 9.1.4. Others

10. Fluidics for Preclinical Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Fluidics for Preclinical Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Fluidics for Preclinical Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Fluidics for Preclinical Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Fluidics for Preclinical Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Fluidics for Preclinical Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Product, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Fluidics for Preclinical Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Danaher Corporation
    • 11.2.2. Thermo Fisher Scientific
    • 11.2.3. Emulate, Inc.
    • 11.2.4. Opentrons Labworks
    • 11.2.5. Dolomite Microfluidics
    • 11.2.6. PerkinElmer, Inc.
    • 11.2.7. Illumina, Inc.
    • 11.2.8. Agilent Technologies
    • 11.2.9. Fluidigm Corporation
    • 11.2.10. Bio-Rad Laboratories
    • 11.2.11. Tecan Group Ltd.
    • 11.2.12. CN Bio Innovations
    • 11.2.13. Mimetas BV
    • 11.2.14. Axion BioSystems
    • 11.2.15. Roche Diagnostics
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제